Navigation Links
AAJ Statement on Supreme Court Decision in Favor of Diana Levine
Date:3/4/2009

WASHINGTON, March 4 /PRNewswire-USNewswire/ -- The U.S. Supreme Court in a 6-3 decision upheld a Vermont jury's decision that Diana Levine, the plaintiff in the Supreme Court case Wyeth v. Levine could hold the drug manufacturer accountable for the injuries she suffered -- which included the loss of her arm -- after taking one of Wyeth's medicines.

Writing the Supreme Court's majority opinion, Justice John Paul Stevens said Food and Drug Administration oversight of drug labeling doesn't prevent the filing of state-level consumer liability lawsuits against drug companies. Joining Stevens in the majority were Supreme Court Justices Anthony Kennedy, David Souter, Ruth Bader Ginsburg, Stephen Breyer and Clarence Thomas.

The following is the statement from American Association for Justice President Les Weisbrod.

"The Supreme Court reaffirmed the principle that state lawsuits perform a valuable and important function in ensuring accountability in uncovering drug hazards. Also, the Supreme Court rejected the FDA's attempts to use the preamble in drug regulations to provide complete immunity to drug manufacturers.

It is clear consumers retained their remedy under law when drug companies have failed to provide adequate warnings for the safe use of their drugs.

Today's decision in favor of Diana Levine proved that even if you are just one person, you can fight for justice and hold your wrongdoer accountable."


'/>"/>
SOURCE American Association for Justice
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
2. AAHSA Statement on Senate Special Committee on Aging Hearing, Health Reform in an Aging America
3. Pelosi Statement on President Obamas Nomination of Governor Sebelius as Secretary of HHS
4. AHIP Statement on Governor Sebelius and Nancy-Ann DeParle
5. NHPCO Statement on MedPAC Recommendations to Congress
6. Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the Presidents 2010 Budget Proposal
7. Statement by American Heart Association President Timothy Gardner, M.D. in Response to Health Proposals in President Obamas Budget
8. AHIP Statement on the Presidents Budget
9. Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
10. Press Statement Issued by Ranbaxy Laboratories Limited
11. NutraCea to Restate Financial Statements for 2007 and 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: